A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 80.40
+0.40 (0.50%)
At close: Mar 27, 2026
A Plus Biotechnology Revenue
In the year 2025, A Plus Biotechnology had annual revenue of 835.89M TWD with 8.61% growth. A Plus Biotechnology had revenue of 214.91M in the quarter ending December 31, 2025, with 5.07% growth.
Revenue
835.89M
Revenue Growth
+8.61%
P/S Ratio
3.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 835.89M | 66.30M | 8.61% |
| Dec 31, 2024 | 769.59M | 94.54M | 14.01% |
| Dec 31, 2023 | 675.05M | 133.20M | 24.58% |
| Dec 31, 2021 | 541.85M | 38.56M | 7.66% |
| Dec 31, 2020 | 503.29M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cowealth Medical Holding | 3.41B |
| Wellell | 2.40B |
| OK Biotech | 1.56B |
| Dynamic Medical Technologies | 1.39B |
| WeLeader Biomedical | 1.11B |
| Bioptik Technology Incorporation | 837.19M |
| Diamond Biotechnology | 698.11M |
| Medimaging Integrated Solution | 661.39M |